AMPA receptor-mediated, calcium-dependent CREB phosphorylation in a subpopulation of auditory neurons surviving activity deprivation.
Although dependence on afferent synaptic activity has been shown for central neurons in every sensory system, the mechanisms of afferent maintenance of target sensory neurons are not understood. Neurons in the cochlear nucleus (CN) require afferent activity for maintenance and survival. One of the earliest changes seen after activity deprivation is an increase in intracellular calcium that leads to the death of 30% of the neuronal population. Sixty minutes after deafferentation, the surviving neurons show increased phosphorylation of the transcription factor calcium/cAMP response element-binding protein (CREB). CREB phosphorylation in activity-deprived CN neurons is dependent on increased intracellular calcium resulting from influx through AMPA receptors and is mediated by calcium/calmodulin-dependent kinases and protein kinase A. We conclude that in CN neurons, the deafferentation-induced increase in calcium activates at least two kinase pathways that phosphorylate CREB in surviving neurons. We hypothesize that this phosphorylation results in the transcription of genes containing the calcium/cAMP response element within their promoter regions, and these genes code for proteins that allow the neurons to compensate for their hypercalcemic, activity-deprived state.
Department of Neurobiology and Anatomy, University of Utah School of Medicine, Salt Lake City, Utah 84132-0001, USA. zlance@mailman.med.utah.edu
L
L
Zirpel
M A
MA
Janowiak
C A
CA
Veltri
T N
TN
Parks
D000818:Animals; D017209:Apoptosis / Q000502:physiology; D002118:Calcium / Q000378:metabolism*; D020013:Calcium Signaling / Q000502:physiology; D054729:Calcium-Calmodulin-Dependent Protein Kinase Type 1; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000378:metabolism; D002470:Cell Survival / Q000502:physiology*; D002645:Chickens; D017626:Cochlear Nucleus / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D017362:Cyclic AMP Response Element-Binding Protein / Q000378:metabolism*; D003714:Denervation / Q000009:adverse effects; D018698:Glutamic Acid / Q000378:metabolism; D009475:Neurons, Afferent / Q000378:metabolism* / Q000473:pathology; D010766:Phosphorylation; D011494:Protein Kinases / Q000187:drug effects / Q000378:metabolism; D018091:Receptors, AMPA / Q000378:metabolism*; D012683:Sensory Deprivation / Q000502:physiology*; D019311:Staurosporine / Q000494:pharmacology
D017362:Cyclic AMP Response Element-Binding Protein; D018091:Receptors, AMPA; D018698:Glutamic Acid; D011494:Protein Kinases; D054729:Calcium-Calmodulin-Dependent Protein Kinase Type 1; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D019311:Staurosporine; D002118:Calcium